Status:
UNKNOWN
Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution
Lead Sponsor:
University Hospital, Brest
Conditions:
Shock
Cardiac Output, Low
Eligibility:
All Genders
18-80 years
Brief Summary
Correlation study between the data provided by two measurement systems, trans- pulmonary thermodilution and ClearSight © (non invasive), to determine the interest in routine use (cardiac output, cardi...
Detailed Description
Since 2014, Edwards society has developed a completely non-invasive monitoring device for measurement of blood pressure and continuous cardiac output without inserting foreign intravascular bodies in ...
Eligibility Criteria
Inclusion
- age\>18
- hospitalized in surgical ICU, with hemodynamic instability or vaso-active drugs
- No opposition formulated
Exclusion
- Impossibility of establishment of one of the cardiac output measurement devices
- Pregnant woman
- Refuse to participate
Key Trial Info
Start Date :
May 10 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 10 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02728791
Start Date
May 10 2016
End Date
December 10 2018
Last Update
January 24 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU BREST, Hôpital de la Cavale Blanche
Brest, France, 29200